ARS Pharmaceuticals has announced the submission of applications seeking the approval of the 2mg epinephrine nasal spray, ...

INDICATION AND IMPORTANT SAFETY INFORMATION FOR neffy (epinephrine nasal spray) INDICATION neffy 2 mg is indicated for emergency treatment of Type I allergic reactions, including anaphylaxis ...

GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of ...

Canada and United Kingdom represent two of the largest markets within the ALK portfolio with plans to expand filings of neffy (epinephrine nasal ...

neffy is the first FDA-approved epinephrine nasal spray, offering a needle-free alternative and enhancing patient safety and compliance during emergency situations. The company's commitment to ...

In the absence of clinical improvement or if symptoms worsen after initial treatment, administer a second dose of neffy in the same nostril with a new nasal spray starting 5 minutes after the ...

“The inclusion of neffy on Express Scripts’ Commercial National Formularies significantly improves access to life-saving allergy treatment,” said Sal Grausso, Head of Market Access at ARS ...

neffy 2 mg is for the treatment of Type I Allergic Reactions, including anaphylaxis, in adults and children who weigh ≥30 kg (66 lbs.). It is the first and only FDA-approved epinephrine nasal spray ...